Search research articles
Contact Us
Filters
Showing results (91-100 of 121) with videos related to
Page
of 13
Sort By:
Infection and Immunity
|
April 1, 1990
Trypanosoma cruzi-induced suppression of human peripheral blood lymphocytes activated via the alternative (CD2) pathway
L A Beltz, F Kierszenbaum, M B Sztein
Immunology
|
March 1, 1994
Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease
F Kierszenbaum, H M Lopez, M B Sztein
The Journal of Protozoology
|
February 1, 1988
Trypanosoma cruzi: a specific surface marker for the amastigote form
M F Lima, L A Beltz, F Kierszenbaum
Tropenmedizin Und Parasitologie
|
March 1, 1983
Exacerbation of Trypanosoma cruzi infection in mice treated with the immunoregulatory agent cyclosporin A
F Kierszenbaum, C A Gottlieb, D B Budzko
Immunology Today
|
April 1, 1989
Decreased human IL-2 receptor expression due to a protozoan pathogen
F Kierszenbaum, M B Sztein, L A Beltz
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1990
Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes
M B Sztein, W R Cuna, F Kierszenbaum
Immunology
|
November 1, 1993
Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?
F Kierszenbaum, H Mejia Lopez, M B Sztein
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1982
Inhibition of antibody-dependent eosinophil-mediated cytotoxicity by heparin
F Kierszenbaum, S J Ackerman, G J Gleich
The Journal of Parasitology
|
October 1, 1981
Antibody-independent, natural resistance of birds to Trypanosoma cruzi infection
F Kierszenbaum, C A Gottlieb, D B Budzko
Infection and Immunity
|
January 1, 1975
Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi
D B Budzko, M C Pizzimenti, F Kierszenbaum
Page
of 13
Search research articles
Search
Showing results (91-100 of 121) with videos related to
Sort By:
Page
of 13
Infection and Immunity
|
April 1, 1990
Trypanosoma cruzi-induced suppression of human peripheral blood lymphocytes activated via the alternative (CD2) pathway
L A Beltz, F Kierszenbaum, M B Sztein
Immunology
|
March 1, 1994
Inhibition of Trypanosoma cruzi-specific immune responses by a protein produced by T. cruzi in the course of Chagas' disease
F Kierszenbaum, H M Lopez, M B Sztein
The Journal of Protozoology
|
February 1, 1988
Trypanosoma cruzi: a specific surface marker for the amastigote form
M F Lima, L A Beltz, F Kierszenbaum
Tropenmedizin Und Parasitologie
|
March 1, 1983
Exacerbation of Trypanosoma cruzi infection in mice treated with the immunoregulatory agent cyclosporin A
F Kierszenbaum, C A Gottlieb, D B Budzko
Immunology Today
|
April 1, 1989
Decreased human IL-2 receptor expression due to a protozoan pathogen
F Kierszenbaum, M B Sztein, L A Beltz
Journal of Immunology (Baltimore, Md. : 1950)
|
May 1, 1990
Trypanosoma cruzi inhibits the expression of CD3, CD4, CD8, and IL-2R by mitogen-activated helper and cytotoxic human lymphocytes
M B Sztein, W R Cuna, F Kierszenbaum
Immunology
|
November 1, 1993
Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?
F Kierszenbaum, H Mejia Lopez, M B Sztein
Journal of Immunology (Baltimore, Md. : 1950)
|
January 1, 1982
Inhibition of antibody-dependent eosinophil-mediated cytotoxicity by heparin
F Kierszenbaum, S J Ackerman, G J Gleich
The Journal of Parasitology
|
October 1, 1981
Antibody-independent, natural resistance of birds to Trypanosoma cruzi infection
F Kierszenbaum, C A Gottlieb, D B Budzko
Infection and Immunity
|
January 1, 1975
Effects of complement depletion in experimental chagas disease: immune lysis of virulent blood forms of Trypanosoma cruzi
D B Budzko, M C Pizzimenti, F Kierszenbaum
Page
of 13